Recall archive / FDA device enforcement
DeRoyal TRACECART SHOULDER ARTHROSCOPY TRACECART, REF 53-1962.02 — FDA record Z-0706-2023
Reported ongoing
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Nov 3, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- DeRoyal TRACECART SHOULDER ARTHROSCOPY TRACECART, REF 53-1962.02
- Reason
- XXX
- Classification
- Class II
- Recalling firm
- DeRoyal Industries Inc
- Quantity
- 117 kits
- Agency-reported status
- Ongoing
- Source record identifier
- Z-0706-2023
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lot Numbers: 56296761 exp 10/01/2023; 56717318 exp 11/01/2023; 57136671 exp 11/01/2023; 57225673 exp 11/01/2023; 57225817 exp 02-01-2024; 57455920 exp 02-01-2024; 57646161 exp 02-01-2024; 57889699 exp 02-01-2024; 58003853 exp 02-01-2024 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
US: Tennessee, Texas, New York, Wisconsin, Florida, Virginia, Massachusetts, Arizona, Missouri, Connecticut, New Jersey, Pennsylvania, North Carolina, Louisiana, Michigan, Minnesota, Ohio, Indiana, Kansas, Illinois, Alabama, Georgia, Mississippi
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- Dec 21, 2022
- Recall initiation date
- Nov 3, 2022
- Center classification date
- Dec 15, 2022
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.